Orise China · CSV Insight

把全球标准落实到生产现场:计算机化系统验证最容易疏漏的地方

Global standards on the plant floor: where computerised system validation slips

By ATS Group · 制药与生物技术 · Orise China

Inspectors no longer stop at the IT boundary. Here is where plant-floor systems fall short, and the checklist to find out before they do.
检查员的目光早已不局限于 IT 边界。这里正是生产现场系统最容易掉队的地方——以及在上一次检查前就发现它们的清单。

Global standards, local team全球标准,本地团队

This is the first article from Orise China on our WeChat account in a while, so a short hello first. Orise, an ATS Corporation company, helps pharma and biotech manufacturers automate, validate and optimise their plants.

好久不见!这是 Orise 中国公众号恢复更新后的第一篇文章,先简单介绍一下我们。Orise 是 ATS 集团旗下公司,致力于帮助制药和生物技术企业实现工厂的自动化、验证与优化。

Here we will share practical notes on validation, automation and compliance for teams working to global standards in China. No sales pitches, just what we see on real projects.

今后,我们将在这里分享验证、自动化和合规方面的实用经验,服务在中国按照全球标准运营的团队。不谈推销,只分享我们在真实项目中的所见所得。

We start with a question we hear more and more on site visits.第一篇,我们从现场走访中越来越常听到的一个问题说起。

“Our MES is validated. What about the systems feeding it?”“我们的 MES 已经验证过了,那为它提供数据的系统呢?”

Most sites put serious effort into validating their enterprise systems: MES, LIMS, eQMS. The validation packages are complete, the audit trails are switched on, and the periodic reviews are scheduled.

大多数工厂在企业级系统(MES、LIMS、eQMS)的验证上投入了大量精力:验证文件齐全,审计追踪已开启,定期回顾也已排期。

The plant floor is often a different story. A SCADA system commissioned with a production line years ago. A building management system controlling cleanroom conditions. A process historian collecting batch data. Standalone instruments in the QC lab. These systems create and hold GMP data, but they usually belong to engineering, not quality. Many have not been reviewed since commissioning.

然而,生产现场往往是另一番景象:多年前随产线一同调试投用的 SCADA 系统;控制洁净区环境的楼宇管理系统(BMS);采集批次数据的过程历史数据库;QC 实验室里的独立仪器。这些系统都在产生和保存 GMP 数据,却通常归工程部门而非质量部门管理,其中不少自调试以来从未被回顾过。

For an inspector, there is no IT boundary. If the data supports a GMP decision, the system that created it is in scope.

在检查员眼中,并不存在“IT 边界”。只要数据支撑 GMP 决策,产生这些数据的系统就在检查范围之内。

Four sources of GMP data that often sit outside validation scope常被排除在验证范围之外的四类 GMP 数据来源

  • DCS and SCADA systems controlling critical process parameters控制关键工艺参数的 DCS 和 SCADA 系统
  • BMS and environmental monitoring in cleanrooms and warehouses洁净区和仓库的 BMS 及环境监测系统
  • Process historians that store batch and trend data存储批次与趋势数据的过程历史数据库
  • Standalone laboratory instruments and their local software独立实验室仪器及其本地软件

What inspectors commonly find on the plant floor检查员在生产现场的常见发现

Across sites, the same three findings come up again and again:

在不同的工厂,以下三类问题反复出现:

  • Shared operator logins. One account for the whole shift means nobody can show who did what.共用操作员账号。整个班次共用一个账号,就无法证明“谁做了什么”。
  • Audit trails that are switched on but never reviewed. The record exists, but nobody can say who reviewed it, when, or what they did about it.审计追踪已开启,却从未审核。记录虽在,却没人说得清由谁审核、何时审核、发现问题后如何处理。
  • Systems owned by engineering, not quality. Changes are made to keep the line running, without change control or a validation impact assessment.系统由工程部门而非质量部门管理。为保证产线运行而做的修改,未经变更控制,也没有进行验证影响评估。

None of this means the plant is unsafe. It means the evidence chain has gaps, and gaps become findings.

这并不意味着工厂不安全,而是说明证据链存在缺口,而缺口往往就会变成检查缺陷。

The bar is rising, in Europe and in China标准正在提高:欧洲如此,中国亦然

Global expectations are moving in one direction. The European Commission's draft revision of EU GMP Annex 11 (July 2025) adds a full chapter on security, covering patching, firewalls, access control and removable media, and expects unique personal accounts with no shared logins. Legacy plant systems get no exemption.

全球监管要求正朝着同一个方向发展。欧盟委员会于 2025 年 7 月发布的 EU GMP 附录 11 修订草案新增了完整的安全章节,涵盖补丁管理、防火墙、访问控制和移动存储介质管理,并要求使用唯一的个人账号、禁止共用登录。老旧的现场系统也不例外。

In China, NMPA's requirements for drug records and data management set out similar expectations for data integrity, and China's GMP appendix on computerised systems covers validation across the system lifecycle. NMPA has also applied to join PIC/S, the international GMP inspection scheme. For multinational sites, that means one direction of travel: HQ audits, overseas inspections and NMPA inspections increasingly ask the same questions.

在中国,国家药监局发布的《药品记录与数据管理要求(试行)》对数据完整性提出了类似要求,药品 GMP《计算机化系统》附录也对系统全生命周期的验证作出了规定。此外,国家药监局已申请加入国际药品检查合作计划(PIC/S)。对跨国企业的在华工厂而言,这意味着方向是一致的:总部审计、海外检查和国家药监局(NMPA),提出的问题日趋趋同。

Buying new equipment? Five questions to ask before it goes live计划采购新设备?上线前先问这五个问题

The easiest time to close these gaps is before a new system is installed. If you are evaluating new machines or upgrading a line, ask your supplier:

弥补这些缺口的最佳时机,是在新系统安装之前。如果您正在评估新设备或升级产线,不妨先问问供应商:

  1. Does the system support individual user accounts with role-based access?系统是否支持基于角色权限的独立用户账号?
  2. Does the audit trail capture who, what, when and why, including old and new values?审计追踪能否记录“谁、做了什么、何时、为何”,包括修改前后的数值?
  3. Can data be backed up, restored and exported in a readable form?数据能否备份、恢复,并以可读的形式导出?
  4. Does it support compliant electronic signatures (21 CFR Part 11, EU Annex 11)?是否支持符合 21 CFR Part 11 和 EU 附录 11 要求的电子签名?
  5. Will the supplier provide validation documentation your QA team and your global HQ can both use?供应商能否提供质量团队和全球总部都能使用的验证文件?

If the answer to any of these is “no” or “not sure”, it is better to know at FAT than at your next inspection.

只要有一个问题的答案是“否”或“不确定”,在 FAT(工厂验收测试)阶段发现,总好过在下一次检查中被发现。

One partner across IT and OT一个合作伙伴,覆盖 IT 与 OT

Orise validates both sides of the boundary: enterprise platforms such as MES, LIMS and eQMS, and automation systems such as Emerson DeltaV, Siemens PCS7, AVEVA PI, SCADA and BMS. One risk-based approach, aligned with GAMP 5, covers the whole estate instead of a separate vendor per system. Our team in China works to the same methods as our teams in Europe.

Orise 的验证服务横跨 IT 与 OT 两端:既包括 MES、LIMS、eQMS 等企业平台,也包括艾默生 DeltaV、西门子 PCS7、AVEVA PI、SCADA 和 BMS 等自动化系统。我们以符合 GAMP 5 的基于风险的方法覆盖全部系统,无需为每个系统单独寻找供应商。Orise 中国团队与欧洲团队采用相同的方法开展工作。

Get the CSV Compliance Checklist获取《CSV 合规检查清单》

Our CSV Compliance Checklist for Pharma & Biotech covers more than 40 checks across GAMP 5, 21 CFR Part 11, EU GMP Annex 11 and PIC/S data integrity guidance, plus a readiness check for the draft Annex 11 and the new Annex 22 on AI. Every check carries its clause reference. The checklist is currently in English. You can get it in one step at the end of this article.

我们的《制药与生物技术 CSV 合规检查清单》包含 40 余项检查要点,覆盖 GAMP 5、21 CFR Part 11、EU GMP 附录 11 及 PIC/S 数据完整性指南,并附有针对附录 11 修订草案和新增人工智能附录 22 的准备度自查。每一项检查均标注对应条款。清单目前为英文版,获取方式见文末。

One step: scan the QR code, add Orise on WeCom and reply “CSV”. We will send you the checklist and, if you are coming to CIPM, arrange a time to meet.

只需一步:扫描下方二维码,添加 Orise 企业微信,回复“CSV”,即可获取检查清单;如您将参加 CIPM,我们也会与您约定见面时间。

扫码添加 Orise 企业微信

扫码添加 Orise 企业微信 · 回复“CSV”

Hotline: 400 108 8529  ·  Email: asia.info@orise.com  ·  Website: www.orise.com.cn